A029
IMPLICATIONS OF EMERGENCY DEPARTMENT PRESENTATION FOR HEAD AND NECK CANCER SURGERY
Functional Outcomes / Quality
Alizabeth K Weber, MD; James A Gallogly, MD; Jennifer V Brinkmeier, MD; Sean T Massa, MD, MSCI
Saint Louis University School of Medicine
A030
ASSESSING THE NUTRITIONAL RISK INDEX AS A PREDICTOR OF POSTOPERATIVE COMPLICATIONS IN HEAD AND NECK CANCER SURGERY
Rushi Patel, BA; Vraj P Shah, BS; Prayag Patel, MD; Jean A Eloy, MD, FACS, FARS
Rutgers New Jersey Medical School
A031
OPIOID PRESCRIBING PATTERNS ACROSS HEAD AND NECK CANCER ONCOLOGY TEAMS AND OTOLARYNGOLOGY PROVIDERS
Neelam Phalke, MD1; Christine Settoon, MD1; Michael Olejniczak, MD2; John N Poche, MD1; Delaney Sheehan, MD3; Lee McDaniel, PhD4; Ashley C Mays, MD1
1Louisiana State University Otolaryngology; 2Louisiana State University General Surgery; 3University of Alabama Otolaryngology; 4Louisiana State University Department of Public Health
A032
APPLICATION OF FIBRIN SEALANT TO THE TRANSORAL SURGICAL DEFECT SIGNIFICANTLY REDUCES OPIOID USE AND POSTOPERATIVE PAIN
Samantha M Cleveland, MD1; Stacey L Tannenbaum, PhD2; Crista Horton, MD2; Ryan H Sobel, MD3
1Department of Surgery, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A; 2Broward Health Research Institute, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A; 3Division of Head & Neck Surgery and Oncology, Department of Surgery, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A
A033
SURVIVAL IMPROVEMENT IN LOW-INCOME PATIENTS WITH ORAL CAVITY CARCINOMA: A HOSPITAL BASED STUDY
Jobran Mansour, MD1; Payam Entezami, MD1; Mark Landry, MD1; Ameya Asarkar, MD1; Farhoud Faraji, MD, PhD2; Cherie-Ann Nathan, MD1; John Pang, MD1
1LSU Health Shreveport; 2UC San Diego Health
A035
IMPACT OF PREOPERATIVE CARE ON CLINICAL OUTCOMES AFTER TOTAL LARYNGECTOMY
Tracy Z Cheng, MD, MHS; Randall Harley, BS; Baraa Nawash, BA; Li Wang, MS; Mohamed Issa, MD; Seungwon Kim, MD
UPMC
A037
MENTAL HEALTH AND QUALITY OF LIFE IN HEAD AND NECK CANCER SURVIVORSHIP
Nicholas R Lenze, MD, MPH1; Jeannette T Bensen, MS, PhD2; Wendell G Yarbrough, MD, MMHC2; Andrew G Shuman, MD1
1University of Michigan; 2University of North Carolina
A038
PSYCHOLOGICAL ADJUSTMENT TO ACTIVE SURVEILLANCE VERSUS IMMEDIATE SURGERY FOR LOW-RISK PAPILLARY THYROID CANCER: A PILOT STUDY
Gabriella T Seo, BS1; Mark L Urken, MD, FACS, FACE2; Lauren E Wein, BA1; Michael P Saturno, BA1; Monica H Xing, BA1; Lauren E Yue, BA1; Eric Dowling, MD2; Tracey Revenson, PhD3; Katherine J Roberts, MPH, MS, EdD4; R M Tuttle, MD5
1Thyroid, Head and Neck Cancer (THANC) Foundation; 2Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai; 3Department of Psychology, The Graduate Center at The City University of New York (CUNY); 4Department of Health and Behavior Studies, Teachers College, Columbia University; 5Endocrinology Service-Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center
A039
OUTCOMES OF THE FACELIFT INCISIONAL APPROACH IN NECK DISSECTION
Benjamin T Ostrander, MD, MSE; Matthew N Harmon, BS; Vanessa K Yu, BS; Joseph A Califano, MD
University of California San Diego
A040
ORAL TOXICITIES ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A META ANALYSIS OF CLINICAL TRIALS
Akanksha Srivastava, BDS, MSc, MDSc1; Graciela Nogueras Gonzalez, MPH2; Yimin Geng, MSLIS, MS2; Jeffrey Myers, MD, PhD2; Yisheng Li2; Aung Naing, MD2; Mark S Chambers, DDS, MS2
1University of Illinois at Chicago; 2University of Texas MD Anderson Cancer Center
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX